Month: February 2021

TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading international specialty insurance provider, today announced financial results for the fourth quarter and year ended December 31, 2020.David Clare, President and CEO of Trisura, stated, “We are pleased with Trisura’s progress, generating net income of $10.9 million in the fourth quarter and $32.4 million for the year – both significant increases over the prior periods. Strong results in Canada, accelerating profitability in the US, improved asset liability matching in our Reinsurance business and investment gains produced a 13.4% return on equity, approaching our mid-teens target ahead of plan.In the context of significant top-line growth in Canada, disciplined underwriting generated a strong 85.5% combined ratio for...

ATLANTA, Feb. 10, 2021 (GLOBE NEWSWIRE) — HAVERTYS (NYSE: HVT and HVT.A) will release fourth quarter and full-year 2020 financial results on Wednesday, February 17, 2021, after the market closes. The company will host a conference call with investors and analysts on Thursday, February 18, 2021 at 10:00 a.m. (ET) to discuss the results of its operations.Havertys invites interested parties to listen to the live audiocast of the conference call at its website, havertys.com. A replay will be available at the website or via telephone at approximately 1:00 p.m. (ET) through Thursday, February 25, 2021. The number to access the telephone playback is 1-888-203-1112 (access code: 4378900).About HavertysHavertys (NYSE: HVT and HVT.A), established in 1885, is a full-service home furnishings retailer with 120 showrooms in 16 states in the Southern...

NEW HAVEN, Conn., Feb. 10, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that it has entered into an agreement with an arm’s length third party pursuant to which Bioasis has agreed to issue 300,000 common shares to the third party at a deemed price of $0.3975 per share in order to resolve a contractual dispute. The shares for debt settlement remains subject to approval by the TSX Venture Exchange (the “TSXV”). The common shares issued pursuant to the shares...

HOUSTON, Feb. 10, 2021 (GLOBE NEWSWIRE) — Oil States International, Inc. (NYSE:OIS) announced today that it has entered into a new $125 million asset-based revolving credit agreement (the “Credit Agreement”). Wells Fargo Bank, National Association is the administrative agent for the Credit Agreement. In addition to Wells Fargo, lenders under the Credit Agreement include Bank of America, National Association, JPMorgan Chase Bank, N.A. and Royal Bank of Canada. Borrowing availability under the Credit Agreement is based on eligible U.S. receivables and inventory. The Credit Agreement replaces Oil States’ existing $200 million revolving credit facility. The maturity date of the Credit Agreement is February 10, 2025.The Credit Agreement contains customary representations, warranties, covenants, terms and conditions...

TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of software, data solutions and independent advisory services to the global commercial real estate (“CRE”) industry, announces that Newmark Valuation & Advisory (“Newmark V&A”), a leading industry innovator, will utilize cloud-enabled ARGUS Enterprise (“AE”), an asset and investment management solution.Through an extensive set of application programming interfaces (“API”) as well as the ability to connect CRE datasets, sources and applications, cloud-enabled AE will provide Newmark V&A a tool to automate complex cash flow reporting requirements, increase efficiencies within the valuation process and deliver analytics to clients.“We are committed to leveraging innovative technology to differentiate our Newmark...

NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced results from the Phase 3 randomized controlled trial of its allogeneic mesenchymal precursor cell (MPC) therapy rexlemestrocel-L in 404 enrolled patients with chronic low back pain (CLBP) due to degenerative disc disease (DDD) refractory to conventional treatments. The results indicate that a single injection of rexlemestrocel-L may provide a safe, durable, and effective opioid-sparing therapy for patients with chronic inflammatory back pain due to degenerative disc disease, and that greatest benefits are seen when administered earlier in the disease process before irreversible fibrosis of the intervertebral disc has occurred.“The durable pain reduction for...

DENVER, Feb. 10, 2021 (GLOBE NEWSWIRE) — General Cannabis Corp (OTCQB: CANN) today announced that it has raised an additional $1.66 million of its senior convertible promissory notes, bringing the total amount raised in the round to $4.6 million. The additional capital will be used to make capital improvements at SevenFive Farm, the Company’s 17,000 square foot light deprivation greenhouse cultivation facility, to extinguish the remainder of its outstanding 15% debt due in 2022 and to provide operating cash.Steve Gutterman, CEO of General Cannabis, stated, “We are pleased to have oversubscribed our convertible note offering, and we are excited to add a new capital partner as another long-term minded, value-added investor. We will deploy these additional funds prudently to continue to build the business and strengthen the balance...

DUBLIN, Ireland and CHICAGO, Feb. 10, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the underwriter of its previously announced underwritten public offering of ordinary shares, which closed on February 8, 2021, has exercised in full its option to purchase additional ordinary shares at the public offering price, less underwriting discounts and commissions. After giving effect to the sale of 5,217,391 additional ordinary shares in the option closing, the total number of ordinary shares sold by the Company in the offering increased to 40,000,000 shares, which resulted in aggregate...

AUSTIN, Texas, Feb. 10, 2021 (GLOBE NEWSWIRE) — Bumble Inc. announced today the pricing of its initial public offering of 50,000,000 shares of its Class A common stock at a price to the public of $43.00 per share. Bumble has granted the underwriters a 30-day option to purchase up to an additional 7,500,000 shares of Class A common stock. The shares are expected to begin trading on the Nasdaq Global Select Market on February 11, 2021 under the symbol “BMBL”.Bumble intends to use the proceeds (net of underwriting discounts) from the issuance of 9 million shares to repay a portion of its senior secured term loan facilities and for general corporate purposes, and to bear the expenses of the offering. Bumble intends to use the proceeds (net of underwriting discounts) from the issuance of 41 million shares (or 48.5 million shares if the...